Medical ozone therapy as a potential treatment modality for regeneration of damaged articular cartilage in osteoarthritis

被引:92
作者
Manoto, Sello Lebohang [1 ]
Maepa, Makwese Johaness [1 ]
Motaung, Shirley Keolebogile [1 ]
机构
[1] Tshwane Univ Technol, Dept Biomed Sci, Fac Sci, ZA-0083 Pretoria, South Africa
关键词
Osteoarthritis (OA); Articular cartilage; Ozone (O-3) therapy; Reactive oxygen species (ROS); MESENCHYMAL STEM-CELLS; NF-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; UP-REGULATION; ACTIVATION; MODEL; ANTIOXIDANTS; CHONDROCYTES; REPERFUSION;
D O I
10.1016/j.sjbs.2016.02.002
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
Osteoarthritis (OA) is the most common degenerative joint disease and a growing health problem affecting more than half of the population over the age of 65. It is characterized by inflammation in the cartilage and synovium, resulting in the loss of joint structure and progressive damage to the cartilage. Many pro-inflammatory mediators are elevated in OA, including reactive oxygen species (ROS) such as nitric oxide (NO) and hydrogen peroxide (H2O2). Damaged articular cartilage remains a challenge to treat due to the limited self-healing capacity of the tissue and unsuccessful biological interventions. This highlights the need for better therapeutic strategies to heal damaged articular cartilage. Ozone (O-3) therapy has been shown to have positive results in the treatment of OA; however the use of O-3 therapy as a therapeutic agent is controversial. There is a perception that O-3 is always toxic, whereas evidence indicates that when it is applied following a specified method, O-3 can be effective in the treatment of degenerative diseases. The mechanism of action of O-3 therapy in OA is not fully understood and this review summarizes the use of O-3 therapy in the treatment of damaged articular cartilage in OA. (C) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:672 / 679
页数:8
相关论文
共 55 条
[1]
Agrogiannis G, 2008, INT J OZONE THERAPY, V7, P7
[2]
Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion [J].
Ajamieh, HH ;
Menéndez, S ;
Martínez-Sánchez, G ;
Candelario-Jalil, E ;
Re, L ;
Giuliani, A ;
Fernández, OSL .
LIVER INTERNATIONAL, 2004, 24 (01) :55-62
[3]
Altman N., 2007, OXYGEN PRESCRIPTION, P30
[4]
Ashkavand Z., 2013, Journal of Pharmacy Research, V7, P132, DOI DOI 10.1016/J.JOPR.2013.01.008
[5]
PYRROLIDINE DITHIOCARBAMATE, A POTENT INHIBITOR OF NUCLEAR FACTOR KAPPA-B (NF-KAPPA-B) ACTIVATION, PREVENTS APOPTOSIS IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS AND THYMOCYTES [J].
BESSHO, R ;
MATSUBARA, K ;
KUBOTA, M ;
KUWAKADO, K ;
HIROTA, H ;
WAKAZONO, Y ;
LIN, YW ;
OKUDA, A ;
KAWAI, M ;
NISHIKOMORI, R ;
HEIKE, T .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) :1883-1889
[6]
Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production [J].
Bocci, V ;
Valacchi, G ;
Corradeschi, F ;
Fanetti, G .
MEDIATORS OF INFLAMMATION, 1998, 7 (05) :313-317
[7]
Bocci VA, 2006, ARCH MED RES, V37, P425, DOI 10.1016/j.arcmed.2005.08.006
[8]
Bocci V, 2011, OZONE: A NEW MEDICAL DRUG, SECOND EDITION, P1, DOI 10.1007/978-90-481-9234-2_1
[9]
Inhibition of inducible NO synthase by TH2 cytokines and TGFβ in rheumatoid arthritic synoviocytes:: Effects on nitrosothiol production [J].
Borderie, D ;
Hilliquin, P ;
Hernvann, A ;
Lemarechal, H ;
Kahan, A ;
Menkes, CJ ;
Ekindjian, OG .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2002, 6 (03) :271-282
[10]
Borrelli E., 2015, J ARTHRITIS, V4, P1